Scotland has become the UK leader in anti-cancer drug manufacturing with the opening of Cancer Research UK's £2 million drug-formulation unit at the University of Strathclyde. Scientists there will convert drug discoveries into forms that can be tested on patients, such as tablets or solutions for injection.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.
